Skip to content
Screener

EyePoint, Inc. EYPT Q2 2026 earnings

Reported August 5, 2026 · Before market open

Revenue$507.0KBeat by $55.8K
EPS-$1.09Miss by $0.08
Revenue estimate$451.2K
EPS estimate-$1.01
“The LUGANO and LUCIA data readouts represent transformative advancement in the wet AMD landscape, potentially positioning DURAVYU as the foundational treatment option for sustained patient care.”
Jay S. Duker

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$231.2K
EPS estimate-$0.91

Financials

Q2 2026

Income statement

See full
Revenue$507.0K-90.5%
Operating income-$97.4M-56.5%
Net income-$94.5M-59.0%
EPS (diluted)-$1.09-28.2%

Balance sheet

See full
Cash & equivalents$110.5M+55.3%
Total debt$22.4M-5.7%
Total equity$166.4M-32.4%
Total assets$228.2M-24.2%

Cash flow

See full
Operating cash flow-$62.3M+0.4%
CapEx$1.2M-1.6%
Free cash flow-$63.5M+0.4%

Valuation & ratios

Valuation

as of 09/17/26
See full
Market cap$297.43M-68.4%
Enterprise value$209.34M-76.6%
P/S106.6×+88.5×

Profitability

See full
Operating margin-11,365.2%-11,754pp
Net margin-10,994.7%-11,355pp
FCF margin-9,726.7%-10,132pp

Returns & leverage

See full
Return on equity-148.7%-13,871pp
Debt / equity0.1×0.0×
Current ratio4.5×-3.5×

Segments

By product

See full
License And Collaboration Agreement$507.0K-90.5%
Product Rights Agreement--100%
Royalty-—

FAQ

When did EyePoint, Inc. report Q2 2026 earnings?
EyePoint, Inc. (EYPT) reported Q2 2026 earnings on August 5, 2026 before market open.
What were EyePoint, Inc.'s Q2 2026 revenue and EPS?
EyePoint, Inc. reported revenue of $507.0K and eps of $-1.09 for Q2 2026.
Did EyePoint, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $451.2K by $55.8K. EPS missed the consensus estimate of $-1.01 by $0.08.
How did EyePoint, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 90.5% from $5.3M a year earlier and eps declined 28.2% from $-0.85.
Where can I find EyePoint, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-333821) and the 10-Q periodic report (0001193125-26-335037) directly on SEC EDGAR. The filing index links above go to sec.gov.